EQS-News / 17/10/2016 / 12:20 UTC+8 Acornea Conquers the Darkness Innovation brings light to the blind around the world Chicago, Illinois, October 16th An Eye-Opennijg innovation: Acornea makes a breakthrough in regenerative medicine as an innovation with the world's first bio-engineered cornea that brings light to the blind. The product is named as Acornea by China Regenerative Medicine International, a medical group based in Hong Kong. The product: Cornea is the clear outer covering of the eyeball. Acornea is a bio-engineered product that can be used as a replacement of human cornea for the blind to see again. The main body of Acornea is derived from other animals such as pigs and biologically treated to make it compatible to humans. Other advantages of Acornea are the following special features: great transparency, less likely to get affected, easy to store and transport, and it does not require any kind of preserving fluid or complicated storage conditions. Moreover, the greatest benefit to the patients is that patients do not have to use lifelong immunosuppressive drugs after Acornea procedure in contrast with the human cornea transplant. Acornea has already been successfully used in curing patients. It proves to be working. The past 2 years witnessed 200 patients who have received Acornea transplant in China ranging from 11 month infant to 70- year-old adult. The result turned out to be successful. What is more inspiring is that the technology has been repeatedly proven to be effective, and it is now ready for global market. The scientist: So much appreciation should go to Dr. Shi, weiyun, professor from China Regenerative Medicine International. Dr. Shi is the Chairman of China Medical Association and the director of Cornea Medicine and Studies. As a world famous scientist at the top, Dr. Shi has been practicing eye medicine for more than 30 years and has conducted more than 10,000 eye surgeries. Dr. Shi is truly one of the creators of this revolutionary technology by CRMI. The manufacturer: China Regenerative Medicine International Limited ("CRMI") is a 20-year-old medical institution. Located in Hong Kong, CRMI has invested billions of dollars in regenerative medicine and tissue engineering products. With more than 10 year's persistent efforts in medical research, CRMI has become the #1 business entity in both regenerativemedicine and tissue engineering, as well as stem cell and other health care products. CRMI has a good number of production facilities all over china such as Xi'an, Shengzhen, Tianjing and Suzhou, etc. CFDA approval: With over 10 years painstaking effort, Acornea was finally Approved by China FDA in April 2015, CRMI is the sole patent owner of Acornea products and ready to commercialize the products for the benefit of those who suffer from the blind world, and Acornea will bring light back to their life again. Final words: As the Nobel Prize winner, Dr. Gilbert once said: "Within the next 50 years, the mankind will be able to develop all human organs." The China Regenerative Medicine International is now just doing that! Acornea, an absolute innovation, will bring light to the blind. Acorena transplant may also unprecedentedly eliminate the remedies of lifelong immunosuppression. For more information, please visit: crmi.hk/s/about_group.php China Regenerative Medicine International Telephone: (852)3966-8388 Fax: (852)2802-0026 E-mail：info@crmi.hk Address：10th floor， Dah Sing Financial Center，108 Gloucester Road Wanchai， Hong Kong Please also contact: XiaoLu Li： Tel: (337) 326-4691 Mobil：(646)287-1688 Email: lcbal3c@gmail.com Chan Chun Fung： Tel: (852)90617622 Email: Anthony.chan@ CRMI.hk Zhengkang Shao： Tel：(852)39668388 Mobil: (852) 59195330 Email: Shao Zhengkang@CRMI.hk
---------------------------------------------------------------------------
Document: http://n.eqs.com/c/fncls.ssp?u=OXEUIGSHCY Document title: CRMI: Acornea Conquers the Darkness Innovation brings light to the blind around the world
---------------------------------------------------------------------------
17/10/2016 Dissemination of a Press Release, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Media archive at www.todayir.com
---------------------------------------------------------------------------
511845 17/10/2016
---------------------------------------------------------------------------
Document: http://n.eqs.com/c/fncls.ssp?u=OXEUIGSHCY Document title: CRMI: Acornea Conquers the Darkness Innovation brings light to the blind around the world
---------------------------------------------------------------------------
17/10/2016 Dissemination of a Press Release, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Media archive at www.todayir.com
---------------------------------------------------------------------------
511845 17/10/2016
